ImmunoGen, Inc.
Cytotoxic benzodiazepine derivatives

Last updated:

Abstract:

The invention relates to novel benzodiazepine derivatives with antiproliferative activity and more specifically to novel benzodiazepine compounds of formula (I)-(VI). The invention also provides conjugates of the benzodiazepine compounds linked to a cell-binding agent. The invention further provides compositions and methods useful for inhibiting abnormal cell growth or treating a proliferative disorder in a mammal using the compounds or conjugates of the invention.

Status:
Grant
Type:

Utility

Filling date:

15 Jun 2020

Issue date:

14 Sep 2021